Last edition
News about "Jubilant Pharmova"
Jubilant Generics Roorkee facility receives USFDA's communication on classification report
As per the filing, the company currently supplies one product to the US market that contributes low single-digit revenue to Jubilant Pharmova revenues
Jubilant Pharmova | 31/10/2022 | By Sudeep Soparkar | 915
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members